Lochner Daniel 4
4 · Tectonic Therapeutic, Inc. · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Tectonic Therapeutic (TECX) CFO Daniel Lochner Buys Stock
What Happened
- Daniel Lochner, Chief Financial Officer of Tectonic Therapeutic (TECX), bought 6,000 shares in an open-market purchase on 2026-02-10. The reported weighted-average price was $21.61 per share, for a total transaction value of about $129,660. This is a purchase (acquisition) rather than a sale.
Key Details
- Transaction date: 2026-02-10; Filing date: 2026-02-11 (timely filing).
- Transaction type/code: Open market purchase (P).
- Shares purchased: 6,000; weighted-average price: $21.61; total value: ~$129,660.
- Footnote: The $21.61 is a weighted-average — trades occurred at prices ranging from $21.24 to $21.82. The reporting person will provide a breakdown of shares per price on request.
- Shares owned after transaction: Not reported in this filing.
- No 10b5-1 plan, option exercise, gift, or tax-withholding noted in this filing.
Context
- Insider purchases can be interpreted as a personal investment signal, but do not prove future company performance; retail investors should consider this alongside broader fundamental and market information. This filing reports a straightforward open-market buy with no derivatives or sales involved.
Insider Transaction Report
Form 4
Lochner Daniel
Chief Financial Officer
Transactions
- Purchase
Common Stock
[F1]2026-02-10$21.61/sh+6,000$129,660→ 32,044 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.24 to $21.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Signature
/s/ Daniel Lochner|2026-02-11